Wess J - Search Results

1

Site-directed mutagenesis of the m3 muscarinic receptor: identification of a series of threonine and tyrosine residues involved in agonist but not antagonist binding.

Wess J, Gdula D, Brann MR. Wess J, et al. EMBO J. 1991 Dec;10(12):3729-34. doi: 10.1002/j.1460-2075.1991.tb04941.x. EMBO J. 1991. PMID: 1657592 Free PMC article.

2

Role of conserved threonine and tyrosine residues in acetylcholine binding and muscarinic receptor activation. A study with m3 muscarinic receptor point mutants.

Wess J, Maggio R, Palmer JR, Vogel Z. Wess J, et al. J Biol Chem. 1992 Sep 25;267(27):19313-9. J Biol Chem. 1992. PMID: 1527051 Free article.

Structure-function relationship studies of the m3 muscarinic acetylcholine receptor have recently identified a series of threonine and tyrosine residues (all located within the hydrophobic receptor core) that are critically involved in acetylcholine binding (Wess, J …

Structure-function relationship studies of the m3 muscarinic acetylcholine receptor have recently identified a series of threonine and tyros …

3

Structural basis of the subtype selectivity of muscarinic antagonists: a study with chimeric m2/m5 muscarinic receptors.

Wess J, Gdula D, Brann MR. Wess J, et al. Mol Pharmacol. 1992 Feb;41(2):369-74. Mol Pharmacol. 1992. PMID: 1538713

4

Antagonist binding profiles of five cloned human muscarinic receptor subtypes.

Dörje F, Wess J, Lambrecht G, Tacke R, Mutschler E, Brann MR. Dörje F, et al. Among authors: wess j. J Pharmacol Exp Ther. 1991 Feb;256(2):727-33. J Pharmacol Exp Ther. 1991. PMID: 1994002

5

Selectivity profile of the novel muscarinic antagonist UH-AH 37 determined by the use of cloned receptors and isolated tissue preparations.

Wess J, Lambrecht G, Mutschler E, Brann MR, Dörje F. Wess J, et al. Br J Pharmacol. 1991 Jan;102(1):246-50. doi: 10.1111/j.1476-5381.1991.tb12161.x. Br J Pharmacol. 1991. PMID: 2043926 Free PMC article.

6

Delineation of muscarinic receptor domains conferring selectivity of coupling to guanine nucleotide-binding proteins and second messengers.

Wess J, Bonner TI, Dörje F, Brann MR. Wess J, et al. Mol Pharmacol. 1990 Oct;38(4):517-23. Mol Pharmacol. 1990. PMID: 2172767

7

Chimeric m2/m3 muscarinic receptors: role of carboxyl terminal receptor domains in selectivity of ligand binding and coupling to phosphoinositide hydrolysis.

Wess J, Bonner TI, Brann MR. Wess J, et al. Mol Pharmacol. 1990 Dec;38(6):872-7. Mol Pharmacol. 1990. PMID: 2174507

8

Molecular genetics of signal transduction by muscarinic acetylcholine receptors.

Brann MR, Wess J, Jones SV. Brann MR, et al. Among authors: wess j. Soc Gen Physiol Ser. 1990;45:105-15. Soc Gen Physiol Ser. 1990. PMID: 2198665 Review. No abstract available.

9

Identification of a small intracellular region of the muscarinic m3 receptor as a determinant of selective coupling to PI turnover.

Wess J, Brann MR, Bonner TI. Wess J, et al. FEBS Lett. 1989 Nov 20;258(1):133-6. doi: 10.1016/0014-5793(89)81633-3. FEBS Lett. 1989. PMID: 2556294 Free article.

10

Mapping of single amino acid residues required for selective activation of Gq/11 by the m3 muscarinic acetylcholine receptor.

Blin N, Yun J, Wess J. Blin N, et al. Among authors: wess j. J Biol Chem. 1995 Jul 28;270(30):17741-8. doi: 10.1074/jbc.270.30.17741. J Biol Chem. 1995. PMID: 7629074 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

348 results

Search Page